pubmed-article:19152396 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:19152396 | lifeskim:mentions | umls-concept:C0020094 | lld:lifeskim |
pubmed-article:19152396 | lifeskim:mentions | umls-concept:C0237401 | lld:lifeskim |
pubmed-article:19152396 | lifeskim:mentions | umls-concept:C0147139 | lld:lifeskim |
pubmed-article:19152396 | lifeskim:mentions | umls-concept:C1335837 | lld:lifeskim |
pubmed-article:19152396 | lifeskim:mentions | umls-concept:C1705603 | lld:lifeskim |
pubmed-article:19152396 | lifeskim:mentions | umls-concept:C0076560 | lld:lifeskim |
pubmed-article:19152396 | lifeskim:mentions | umls-concept:C0017337 | lld:lifeskim |
pubmed-article:19152396 | lifeskim:mentions | umls-concept:C1336626 | lld:lifeskim |
pubmed-article:19152396 | lifeskim:mentions | umls-concept:C0332281 | lld:lifeskim |
pubmed-article:19152396 | lifeskim:mentions | umls-concept:C1527148 | lld:lifeskim |
pubmed-article:19152396 | lifeskim:mentions | umls-concept:C1442734 | lld:lifeskim |
pubmed-article:19152396 | lifeskim:mentions | umls-concept:C1882417 | lld:lifeskim |
pubmed-article:19152396 | lifeskim:mentions | umls-concept:C0279477 | lld:lifeskim |
pubmed-article:19152396 | lifeskim:mentions | umls-concept:C1704619 | lld:lifeskim |
pubmed-article:19152396 | lifeskim:mentions | umls-concept:C1533179 | lld:lifeskim |
pubmed-article:19152396 | lifeskim:mentions | umls-concept:C1880355 | lld:lifeskim |
pubmed-article:19152396 | lifeskim:mentions | umls-concept:C0238815 | lld:lifeskim |
pubmed-article:19152396 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:19152396 | pubmed:dateCreated | 2009-1-22 | lld:pubmed |
pubmed-article:19152396 | pubmed:abstractText | The development of HTLV-1 associated clinical manifestations, such as TSP/HAM and ATLL, occur in 2-4% of the infected population and it is still unclear why this infection remains asymptomatic in most infected carriers. Recently, it has been demonstrated that HTLV uses the Glucose transporter type 1 (GLUT1) to infect T-CD4(+) lymphocytes and that single nucleotide polymorphisms (SNP) in the GLUT1 gene are associated with diabetic nephropathy in patients with diabetes mellitus in different populations. These polymorphisms could contribute to a higher GLUT1 protein expression on cellular membrane, facilitating the entry of HTLV and its transmission cell by cell. This could result in a higher provirus load and consequently in the development of TSP/HAM. To evaluate the role of GLUT1 gene polymorphisms in the development of TSP/HAM in HTLV-1 infected individuals, the g.22999G > T, g.15339T > C and c.-2841A > T sites were analyzed by PCR/RFLP or sequencing in 244 infected individuals and 102 normal controls. The proviral load of the HTLV-1 infected patients was also analyzed using Real Time Quantitative PCR. Genotypic and allelic frequencies of the three sites did not differ significantly between controls and HTLV-1 infected individuals. There was no difference in genotypic and allelic distributions among patients as to the presence or absence of HTLV-1 associated clinic manifestations. As regards the quantification of the provirus load, we observed a significant reduction in the asymptomatic individuals compared with the oligosymptomatic and TSP/HAM individuals. These results suggest that g.22999G > T, g.15339T > C, and c.-2841A > T SNP do not contribute to HTLV-1 infection nor to the genetic susceptibility of TSP/HAM in Brazilian HTLV-1 infected individuals. | lld:pubmed |
pubmed-article:19152396 | pubmed:language | eng | lld:pubmed |
pubmed-article:19152396 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19152396 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:19152396 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19152396 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19152396 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:19152396 | pubmed:month | Mar | lld:pubmed |
pubmed-article:19152396 | pubmed:issn | 1096-9071 | lld:pubmed |
pubmed-article:19152396 | pubmed:author | pubmed-author:Galvão-Castro... | lld:pubmed |
pubmed-article:19152396 | pubmed:author | pubmed-author:TakayanaguiOs... | lld:pubmed |
pubmed-article:19152396 | pubmed:author | pubmed-author:CovasDimas... | lld:pubmed |
pubmed-article:19152396 | pubmed:author | pubmed-author:GadelhaSandra... | lld:pubmed |
pubmed-article:19152396 | pubmed:author | pubmed-author:CostaGiselle... | lld:pubmed |
pubmed-article:19152396 | pubmed:author | pubmed-author:AzevedoRochel... | lld:pubmed |
pubmed-article:19152396 | pubmed:author | pubmed-author:KashimaSimone... | lld:pubmed |
pubmed-article:19152396 | pubmed:author | pubmed-author:MuricyGabriel... | lld:pubmed |
pubmed-article:19152396 | pubmed:author | pubmed-author:OlavarriaVivi... | lld:pubmed |
pubmed-article:19152396 | pubmed:author | pubmed-author:AlcantaraLuiz... | lld:pubmed |
pubmed-article:19152396 | pubmed:copyrightInfo | Copyright 2009 Wiley-Liss, Inc. | lld:pubmed |
pubmed-article:19152396 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:19152396 | pubmed:volume | 81 | lld:pubmed |
pubmed-article:19152396 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:19152396 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:19152396 | pubmed:pagination | 552-7 | lld:pubmed |
pubmed-article:19152396 | pubmed:meshHeading | pubmed-meshheading:19152396... | lld:pubmed |
pubmed-article:19152396 | pubmed:meshHeading | pubmed-meshheading:19152396... | lld:pubmed |
pubmed-article:19152396 | pubmed:meshHeading | pubmed-meshheading:19152396... | lld:pubmed |
pubmed-article:19152396 | pubmed:meshHeading | pubmed-meshheading:19152396... | lld:pubmed |
pubmed-article:19152396 | pubmed:meshHeading | pubmed-meshheading:19152396... | lld:pubmed |
pubmed-article:19152396 | pubmed:meshHeading | pubmed-meshheading:19152396... | lld:pubmed |
pubmed-article:19152396 | pubmed:meshHeading | pubmed-meshheading:19152396... | lld:pubmed |
pubmed-article:19152396 | pubmed:meshHeading | pubmed-meshheading:19152396... | lld:pubmed |
pubmed-article:19152396 | pubmed:meshHeading | pubmed-meshheading:19152396... | lld:pubmed |
pubmed-article:19152396 | pubmed:meshHeading | pubmed-meshheading:19152396... | lld:pubmed |
pubmed-article:19152396 | pubmed:meshHeading | pubmed-meshheading:19152396... | lld:pubmed |
pubmed-article:19152396 | pubmed:meshHeading | pubmed-meshheading:19152396... | lld:pubmed |
pubmed-article:19152396 | pubmed:year | 2009 | lld:pubmed |
pubmed-article:19152396 | pubmed:articleTitle | Polymorphisms at GLUT1 gene are not associated with the development of TSP/HAM in Brazilian HTLV-1 infected individuals and the discovery of a new polymorphism at GLUT1 gene. | lld:pubmed |
pubmed-article:19152396 | pubmed:affiliation | Laboratório Avançado de Saúde Pública, Centro de Pesquisa Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Bahia, Brazil. | lld:pubmed |
pubmed-article:19152396 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:19152396 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
entrez-gene:6513 | entrezgene:pubmed | pubmed-article:19152396 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:19152396 | lld:entrezgene |